Results 31 to 40 of about 4,373 (200)
Anti-glial nuclear antibody (AGNA) is an onconeuroal antibody targeting the nuclei of Bergmann glia in the cerebellum and Anti-SRY-related HMG-box 1 (SOX1).
Jonas Feldheim +4 more
doaj +1 more source
Treatment for Lambert-Eaton myasthenic syndrome [PDF]
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission. Treatments attempt to overcome the harmful autoimmune process, or improve residual neuromuscular transmissionThe objective was to examine the efficacy of treatment in Lambert-Eaton myasthenic syndrome.We searched the Cochrane Neuromuscular Disease Group ...
Michael, Keogh +2 more
openaire +2 more sources
Congenital Lambert-Eaton myasthenic syndrome [PDF]
A 4 year old girl had been hypotonic and areflexic since birth with delayed milestones in motor development. Repetitive stimulation at high rates performed at 3 years elicited an incremental response typical of the Lambert-Eaton Syndrome.
B, Bady, G, Chauplannaz, H, Carrier
openaire +2 more sources
Stimulated single-fiber electromyography (sSFEMG) in Lambert-Eaton syndrome
Objective: To report the clinical features and the neurophysiological approach of a patient with Lambert-Eaton myasthenic syndrome (LEMS), highlighting the diagnostic role of the stimulated single fiber electromyography (sSFEMG).
Vincenzo Todisco +5 more
doaj +1 more source
Paraneoplastic Mononeuritis Multiplex as a Presenting Feature of Adenocarcinoma of the Lung
Paraneoplastic neurologic syndromes are observed in less than 0.1% of cancer patients. Neurologic syndromes in lung cancer include Lambert-Eaton myasthenic syndrome, polyneuropathy, cerebellar degeneration, and rarely mononeuritis multiplex. In this case,
Esra Ekiz +2 more
doaj +1 more source
Tubular aggregates in autoimmune Lambert–Eaton myasthenic syndrome
Tubular aggregates are accumulations of densely packed tubules in muscle fibers, occurring in distinct hereditary and acquired disorders. We present a patient with tubular aggregates and autoimmune Lambert–Eaton myasthenic syndrome.
Funk, F. +9 more
core +1 more source
ABSTRACT This review examines the emerging application of chimeric antigen receptor (CAR) T‐cell therapy in myasthenia gravis (MG), with emphasis on safety, efficacy signals, and future therapeutic potential in treatment‐refractory disease. A comprehensive literature search was conducted across PubMed, medRxiv, bioRxiv, and Google Scholar for studies ...
Tobias Hegelmaier +7 more
wiley +1 more source
Using Intravenous Inmunoglobulin in an Atypical Case of Lambert Eaton Síndrome.
A 48 year-old hypertensive, smoker patient who started presenting a generalized weakness, pait instability,visual disorders and uncontrolled blood pressure is presented. At physical examination quadriparesis and weakness extraocular muscles were found. A
Erélido Hernández Valero +1 more
doaj +2 more sources
ABSTRACT Immune checkpoint inhibitor (ICI) therapies are known to cause immune‐related adverse events (irAEs), including life‐threatening myocarditis, myositis, and myasthenia (MMM) overlap syndrome. Current literature lacks established therapeutic guidelines for effective management with steroid‐sparing agents.
Zeinab Alnahas +3 more
wiley +1 more source
Síndromes paraneoplásicas neurológicas.
Some neurologic syndromes are often associated with neoplasm, as a paraneoplastic disorder. Among them, namely, subacute cerebellar degeneration, sensory neuronopathy, dermatomyositis/polymyositis, Lambert-Eaton myasthenic syndrome and subacute motor ...
A N Morganho +3 more
doaj +1 more source

